Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • LinkedIn
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Arteriosclerosis, Thrombosis, and Vascular Biology

  • My alerts
  • Sign In
  • Join

  • Facebook
  • LinkedIn
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Vascular Biology

Cholesterol Dependence of Vascular ERK1/2 Activation and Growth in Response to Stretch

Role of Endothelin-1

Asad Zeidan, Jonas Broman, Per Hellstrand, Karl Swärd
Download PDF
https://doi.org/10.1161/01.ATV.0000090129.75275.C2
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1528-1534
Originally published August 7, 2003
Asad Zeidan
From the Division of Molecular and Cellular Physiology, Department of Physiological Sciences, Lund University, Biomedical Centre, Lund, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonas Broman
From the Division of Molecular and Cellular Physiology, Department of Physiological Sciences, Lund University, Biomedical Centre, Lund, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Per Hellstrand
From the Division of Molecular and Cellular Physiology, Department of Physiological Sciences, Lund University, Biomedical Centre, Lund, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Swärd
From the Division of Molecular and Cellular Physiology, Department of Physiological Sciences, Lund University, Biomedical Centre, Lund, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Loading

Abstract

Objective— Stretch-induced growth of the vascular wall plays a role in hypertension and neointima formation. Its signal pathways involve integrins, cytoskeleton, membrane receptors, and ion channels, some of which are organized in cholesterol-rich, membrane domains such as lipid rafts or caveolae. This study tested the role of rafts/caveolae in stretch-induced vascular growth by manipulation of membrane cholesterol contents.

Methods and Results— Growth and protein synthesis were induced by mechanical stretch of rat portal veins in vitro. Sucrose gradient centrifugation showed stretch-induced tyrosine phosphorylation primarily in fractions containing caveolin-1. Disruption of membrane caveolae with use of methyl-β-cyclodextrin (mβcd) reduced weight gain, protein synthesis, and DNA synthesis to levels in unstretched, control veins. These effects were partially reversed by restoration of cellular cholesterol contents. Inhibited growth was associated with abolished activation of extracellular signal–regulated kinase (ERK) 1/2 in response to stretch and endothelin-1 (ET-1) but not to angiotensin II. Inhibition of ET-1 type A (ETA) receptors by RF139317 or endothelin-converting enzyme by phosphoramidone abolished stretch-induced ERK1/2 activation, which was, however, unaffected by removal of the endothelium.

Conclusions— Stretch-induced growth signaling in vascular smooth muscle depends on cholesterol-rich, membrane microdomains by a mechanism involving ETA receptors that respond to endogenous ET-1 production.

  • hypertrophy
  • portal vein
  • caveolae
  • ERK1/2
  • cyclodextrin

Blood vessels subjected to increased wall stress undergo structural and biochemical changes, which result in hypertrophy/hyperplasia of vascular smooth muscle. This leads to clinically important alterations in structure and function, as seen in hypertension and graft restenosis.1–3⇓⇓ A complex interaction of smooth muscle and the endothelium, which involves mechanical stimuli such as pressure and flow as well as growth factors and the extracellular matrix, controls vascular growth and differentiation.4,5⇓

See page 1481

The sequence of events that cause stretch-induced vascular growth is largely unknown, although several illuminating observations have been made. Extracellular matrix components and integrins, as well as the cytoskeleton, play important roles as mechanical sensors.6,7⇓ Outside-in signaling by integrins depends on Src family kinases,8 and inhibition of Src decreases extracellular signal–regulated kinase (ERK) 1/2 activation and protein synthesis in blood vessels exposed to increased wall stress.9,10⇓ In parallel with integrin signaling, growth factors produced in response to stretch, eg, angiotensin II (Ang II), endothelin-1 (ET-1), and platelet derived growth factor, act in a paracrine manner.11–14⇓⇓⇓ Activation of the protein kinases Raf, MEK, and ERK1/2 is essential for the resulting growth response.9,10,12,15,16⇓⇓⇓⇓

The distribution of growth factor receptors and Src in the membrane is influenced by the presence of cholesterol-rich, membrane domains.17–20⇓⇓⇓ Lipid rafts are aggregates of cholesterol and glycosphingolipids that lack a defined structure.19 Caveolae have a similar composition and appear as 50- to 100-nm, flask-shaped membrane invaginations.20 The protein caveolin binds cholesterol and stabilizes caveolae.21,22⇓ Purified rafts/caveolae contain receptors, G proteins, and ERK1/2 in addition Src.20 It is therefore reasonable to hypothesize that these specialized membrane domains play a role in stretch signaling. Indeed, evidence for signaling of shear stress through rafts/caveolae has been obtained in endothelial cells.23–25⇓⇓ Such mechanotransduction in the endothelium might modulate contractility and also possibly growth and differentiation of the underlying vascular smooth muscle cells.5 A direct effect of stretch on smooth muscle growth and differentiation is, however, also present,4 and investigation of the role(s) of lipid rafts/caveolae in this response is expected to elucidate mechanisms of vascular hypertrophy.

We have investigated the role of membrane cholesterol in stretch-dependent vascular growth of the rat portal vein in vitro. This vessel has spontaneous activity similar to the myogenic tone of precapillary resistance vessels, and because of its longitudinally oriented smooth muscle cells, the vessel wall might be conveniently stretched by weight loading. Culture under load causes greater contractility, protein synthesis, and cell cross-sectional area relative to unloaded, control veins.10 The stretch response promotes expression of differentiation-related proteins and depends on endogenous production of Ang II and cytoskeletal dynamics.16 Here, we tested whether stretch increases the phosphotyrosine (P-Tyr) contents in caveolin-containing membrane microdomains and examined the effects on growth of cholesterol depletion by cyclodextrin, which disrupts rafts and caveolae.19,22⇓

Methods

Animals, Dissection, and Cholesterol Depletion

Female Sprague-Dawley rats were killed by cervical dislocation, as approved by the Animal Ethics Committee, Lund University. Portal veins were dissected under sterile conditions and cut longitudinally into halves. For cholesterol depletion, strips were incubated with 5 mmol/L methyl-β-cyclodextrin (mβcd) or vehicle in Krebs’ solution (in mmol/L: NaCl 135.5, KCl 5.9, CaCl2 2.5, MgCl2 1.2, HEPES 11.6, and glucose 11.5, pH 7.4) for 1 to 3 hours at 37°C. The 1-hour treatment was used as the standard incubation time, because longer incubations impaired contractility. Cholesterol was reloaded into depleted strips by cholesterol-saturated mβcd (water-soluble cholesterol, Sigma) in Krebs’ solution for 3 hours at 37°C. Before culture, strips were gently blotted and weighed as described.10

Organ Culture

After cholesterol depletion, strips were transferred to culture medium (Dulbecco’s modified Eagle’s medium and Ham’s F-12 medium [1:1, vol/vol], containing 2% dialyzed fetal calf serum, 10 nmol/L insulin, 50 U/mL penicillin, and 50 μg/mL streptomycin) and either left undistended or loaded with a 0.6-g gold weight, which represents a preload approximately optimal for active force development The passive length-tension relation is quite steep, so that a 10% shortening from the loaded length eliminates most of the passive force.10 The culture period was 24 hours, after which the strips were again weighed. No effects of mβcd on growth were observed with longer culture (3 days), presumably reflecting recovery from cholesterol depletion.

Mechanical Recording

Strips were mounted,10 immersed in 0.4 mL Krebs’ solution, and stretched to a passive tension of 2 mN. After equilibration (45 minutes), experimental protocols were started. Contraction was elicited by replacing NaCl with KCl to a final concentration of 140 mmol/L. The cross-sectional area was determined from the length and wet weight.

Protein and DNA Synthesis

For analysis of protein and DNA synthesis rates, [methyl-3H]thymidine or l-[4,5-3H]leucine (Amersham), at activities of 0.2 and 1 μCi/mL, respectively, were added to the culture flasks, and incorporation was determined as described previously.10

Immunoblotting

Tissue was equilibrated for 1 hour in normal Krebs’ solution with or without mβcd, loaded for 5 or 10 minutes in culture medium, and then snap-frozen. ERK phosphorylation was determined by Western blotting.10 Caveolin-1 was detected with the 6B6 antibody26 (a gift from Dr J. Vinten, University of Copenhagen, Copenhagen, Denmark), and tyrosine phosphorylation (P-Tyr), with PY 20 (Transduction Laboratories). Bands were visualized by enhanced chemiluminescence (Lumi-Glo, New England Biolabs or Pierce West-pico). Phosphorylated ERK1/2 was normalized to the total amount of ERK1/2.

Tissue Fractionation by Sucrose Gradient Centrifugation

A detergent-free method to purify caveolae was adopted from that of Song et al.27 Tissues were pulverized in LN2 and suspended in 1 mL of 500 mmol/L Na2CO3 with protease inhibitors (5 μg/mL, Sigma), pH 11. The homogenate was adjusted to 45% sucrose with 1 mL of 90% sucrose in MBS (25 mmol/L MES and 0.15 mol/L NaCl, pH 6.5) and overlayered with 4 mL of 35% sucrose and 4 mL of 5% sucrose, both in MBS with 250 mmol/L Na2CO3. After centrifugation at 39 000 rpm for 22 hours (SW 41, Beckman Instruments), ten 1-mL fractions were collected. For detection of P-Tyr, protein was precipitated with 20% trichloroacetic acid, washed with acetone, and solubilized in sample buffer. When stretched and control veins were compared, the volumes loaded on the gel were adjusted to give equal protein contents in fraction 5. Protein synthesis rates are stretch dependent, but measurable differences in overall protein composition between loaded and unloaded veins do not appear during organ culture for several days,16 and hence, increases in P-Tyr during a 10-minute loading period represent increased phosphorylation of preformed proteins and not increased protein contents.

Electron Microscopy

Veins were fixed (1 to 2 hours) in 2% glutaraldehyde and 1% depolymerized paraformaldehyde in phosphate-buffered saline (pH 7.4, 300 mOsm). After being rinsed in phosphate-buffered saline, veins were postfixed in 1% OsO4 for 60 minutes, rinsed, dehydrated in graded ethanol (70%, 95%, and 100%), and embedded in mounting medium (Durcupan ACM, Fluka). Ultrathin sections were cut, mounted on copper mesh grids, and counterstained with uranyl acetate and lead citrate. Sections were examined in a transmission electron microscope, and photomicrographs were obtained with a CCD camera (Gatan 791 MultiScan). Caveolae, including completely and partially invaginated vesicles (50- to 100-nm diameter) and those with dilated necks found within 100 nm of the plasma membrane, were counted on coded photomicrographs. Membrane length was determined with commercially available software (ImageJ). The photomicrographs used for calculation of caveolar density were obtained randomly and in a similar way for all conditions, but because we concentrated on areas containing either caveolae or their remnants, we cannot exclude a bias toward regions rich in caveolae.

Statistics

Data are presented as mean±SE. Student’s t test was used to test statistical significance. For multiple comparisons, 1-way ANOVA was used. P<0.05 was considered significant.

Results

Stretch Rapidly Increases P-Tyr in Caveolin-1–Containing Membrane Domains

Mechanical stimuli rapidly increase P-Tyr of cellular proteins. To investigate whether stretch increases P-Tyr in caveolae of the intact rat portal vein, a detergent-free method for purification of caveolae by sucrose gradient fractionation was used. Ten minutes of stretch increased P-Tyr of several high-molecular-weight proteins (Figure 1A and 1B,a). P-Tyr increased almost exclusively in the fraction containing the caveolar marker caveolin-1 (Figure 1A). Comparisons (fold differences) of P-Tyr of several protein bands in fraction 5 of stretched versus unstretched veins are shown in Figure 1B,a. Caveolin-1 contents and protein composition in the fractions were the same (Figure 1B,b and Methods). This indicates that the stretch signal involves P-Tyr of several proteins that are located in caveolae.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Stretch increases P-Tyr in caveolin-1–containing membrane domains, and cholesterol depletion collapses smooth muscle caveolae. Caveolae were purified by sucrose density fractionation from control and stretched (10 minutes), nondenuded portal veins. After sodium dodecyl sulfate–polyacrylamide gel electrophoresis and transfer to nitrocellulose, membranes were immunoblotted (IB) with anti–P-Tyr (A, top) and anti–caveolin-1 (A, bottom) antibodies. Loading of the gel was adjusted to give identical amounts of protein in fraction 5. The fold increases in P-Tyr of selected bands in the caveolin-1 fraction, compared with unloaded controls, are shown in B,a. Molecular-weight estimates are indicated below bars. The fold increase for smaller proteins (P43, P65) was determined after longer exposure. Blots in A are representative of 3 independent experiments. Densitometry demonstrated similar contents of caveolin-1 in fraction 5 from loaded (Lo) and unloaded (Unlo) veins (B,b). C,a–C,c show representative smooth muscle membrane areas from a control vein (C,a) and veins treated for 1 (C,b) or 2 (C,c) hours with mβcd (5 mmol/L). Arrows point to caveolae and caveolar remnants. SR indicates sarcoplasmic reticulum. Scale indicated in C,a is identical in C,b and C,c.

Cholesterol Depletion Disrupts Caveolar Structure

Cholesterol was extracted with mβcd (5 mmol/L, 1 to 3 hours),22,28⇓ and membrane profiles were examined by electron microscopy. Caveolae were found as clusters at the cell ends and also along the longitudinal cell axes (Figure 1C,a). After incubation with mβcd for 1 hour, areas of flattened caveolae with dilated openings were present (Figure 1C,b), but in some regions, caveolae appeared normal. After longer treatment (2 to 3 hours), caveolae were more extensively flattened and dilated, and no caveolae of normal appearance were found (Figure 1C,c). The density of caveolae, irrespective of structure, was 3.8±0.4/μm membrane in controls versus 3.8±0.8, 4.3±0.2, and 1.5±0.3 (P<0.01) in preparations treated for 1, 2, and 3 hours, respectively (data from ≥8 photomicrographs per condition in 2 experiments).

Effect of Cholesterol Depletion on Stretch-Induced Growth and Protein Synthesis

Portal veins were cultured for 24 hours under loaded and unloaded conditions after cholesterol depletion for 1 hour. The weight of loaded, control vessels increased under these conditions,10,16⇓ whereas unloaded veins lost weight (Figure 2A). Depletion of cellular cholesterol resulted in weight loss of loaded veins, similar to unloaded controls. Cholesterol-depleted, unloaded veins behaved as unloaded controls.

Figure2
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. Cholesterol depletion abolishes stretch-induced growth of rat portal vein. Portal vein strips, treated as indicated, were subjected to mechanical loading in culture, and wet weight at the end of culture was recorded and normalized to weight before culture (A). Results are mean±SE of 5 to 13 experiments. In B and C, rat portal veins, treated as indicated, were incubated with [3H]leucine and [3H]thymidine for 24 hours. Protein and DNA synthesis rates were measured by scintillation counting. Results are mean±SE of 5 or 6 experiments. *P<0.05 vs loaded controls, †P<0.05 vs loaded and cholesterol (chol)-depleted preparations. DPM indicates disintegrations per minute.

The disruption of caveolar structure with mβcd can be reversed by incubation with cholesterol-saturated mβcd (1 mmol/L cholesterol:5 mmol/L mβcd).28 Incubation with cholesterol-saturated mβcd without prior depletion did not affect weight gain in either loaded or unloaded veins (see online Figure I; available at http://atvb.ahajournals.org), demonstrating that mβcd itself has no effect on growth besides that caused by the extraction of cholesterol. Incubation with cholesterol-saturated mβcd for 3 hours after depletion (1 hour) partially restored the stretch-induced weight gain during the following culture (Figure 2A).

Protein and DNA syntheses were measured by [3H]leucine and [3H]thymidine incorporation, respectively, during culture (Figure 2B and 2C). Cholesterol depletion reduced protein and DNA syntheses in loaded veins toward the levels of unloaded controls. Synthesis recovered significantly, but not completely, when depleted veins were incubated with cholesterol-saturated mβcd before culture. Cholesterol-saturated mβcd alone did not influence leucine incorporation in loaded and unloaded veins, again excluding the possibility of nonspecific effects of mβcd on growth (see online Figure I; available at http://atvb.ahajournals.org). Neither protein synthesis nor DNA synthesis was affected by cholesterol depletion in unloaded veins. Extraction with mβcd had no effect on force in response to high-K+ depolarization in fresh strips (13±2 vs 11±2 mN/mm2; n=10, P=NS) or in veins cultured under load after extraction (8±3 vs 6±1 mN/mm2; n=10, P=NS). However, the amplitude of the regular spontaneous activity characteristic of the portal vein declined after cholesterol depletion (not shown).

Effect of Cholesterol Depletion on Stretch-Induced ERK1/2 Activation

Stretch-induced growth of the portal vein requires ERK1/2 phosphorylation,10 which is likely to be represented by the P-Tyr labeling in the 43-kDa region of the caveolar fraction in Figure 1A and 1B. Veins were therefore stretched for 5 minutes, and ERK1/2 phosphorylation was determined by Western blotting. We first verified that mβcd did not have any nonspecific effect on ERK1/2 activation by using cholesterol-saturated mβcd (Figure 3A). Cholesterol depletion, on the other hand, inhibited ERK1/2 phosphorylation in stretched veins by ≈70% (Figure 3B). Significant recovery of stretch activation was observed after replenishing the cholesterol in depleted veins (Figure 3B).

Figure3
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 3. Stretch-induced ERK1/2 phosphorylation (P-ERK1/2) is inhibited by cholesterol depletion. Phosphorylation of ERK1/2 was determined at the end of a 5-minute period in the absence or presence of load and expressed relative to phosphorylation in loaded, control veins. A demonstrates lack of effect of cholesterol (chol)-saturated mβcd (1 mmol/L cholesterol:5 mmol/L mβcd) on ERK1/2 activation by stretch. B demonstrates inhibition of ERK1/2 phosphorylation in stretched veins by cholesterol depletion. Cholesterol replenishment after prior depletion is indicated by mβcd-chol. Below the bar graphs, representative Western blots of P-ERK1/2 and total ERK1/2 are shown. Results are mean±SE of 3 (A) or 6 (B) experiments. *P<0.05 vs loaded controls, †P<0.vs loaded and cholesterol-depleted preparations.

Effect of Cholesterol Depletion on ERK1/2 Activation by Ang II and ET-1

Part of the stretch-induced ERK1/2 activation in the portal vein depends on endogenous release of Ang II.16 We therefore investigated the effect of cholesterol depletion on responses to Ang II. Addition of Ang II (10 μmol/L, 5 minutes) increased ERK1/2 phosphorylation in loaded and unloaded control as well as cholesterol-depleted veins. The effects of load and Ang II were additive (Figure 4). Although cholesterol depletion inhibited stretch-induced activation of ERK1/2, the additional response to Ang II in both loaded and unloaded veins was unaffected.

Figure4
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 4. Cholesterol depletion does not impair Ang II-induced ERK1/2 phosphorylation (P-ERK1/2). Rat portal vein strips, treated as indicated, were stretched and/or stimulated with 10 μmol/L Ang II for 5 minutes followed by snap-freezing and Western blotting. Results are mean±SE of 4 experiments. Western blots from a typical experiment of P-ERK1/2 and total ERK1/2 are shown below.

Addition of ET-1 increased ERK1/2 phosphorylation in both stretched and unstretched preparations, whereas the ET-1 type A (ETA) receptor blocker RF139317 (1 μmol/L) reduced ERK1/2 phosphorylation of both stretched and unstretched preparations below their respective control values (Figure 5). This suggests that endogenous ET-1 production contributes to ERK1/2 activity, as also shown by the finding that the endothelin-converting enzyme inhibitor phosphoramidone (PA, 10 μmol/L) inhibited activation of ERK1/2 by stretch (loaded control, 100%; unloaded, 39±4%; loaded plus PA, 40±4%; unloaded plus PA, 34±2%; n=4 for all, P<0.05 for effect of PA). Although ERK1/2 activation due to endogenous production of Ang II and ET-1 seems to play a role in the stretch response, their dependence on membrane cholesterol differs, because mβcd completely inhibited activation of ERK1/2 by exogenous ET-1 as well as by stretch (Figure 5).

Figure5
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 5. Role of ET-1 receptors in stretch-induced ERK1/2 phosphorylation (P-ERK1/2). Portal vein strips were treated with 10 nmol/L ET-1, the ETA receptor antagonist RF139317, and mβcd for 5 minutes followed by snap-freezing and Western blotting. Results are mean±SE of 4 to 8 experiments of 2 different designs, both including loaded and unloaded veins, which allowed direct comparisons. Western blots of P-ERK1/2 and total ERK1/2 from typical experiments are shown below the bar graph. *P<0.05 vs loaded controls, †P<0.05 for indicated comparisons.

Role of the Endothelium

In view of the reported role of caveolae as mechanosensors in endothelial cells, the endothelium was removed, and the effect on stretch-induced ERK1/2 activation was examined. Scraping of the luminal vessel surface abolished endothelial nitric oxide synthase labeling, whereas stretch-induced ERK1/2 activation remained unaffected (Figure 6A).

Figure6
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 6. Endothelial denudation does not influence stretch-induced ERK1/2 activation, and cholesterol depletion does not displace ERK1/2 from caveolae. Summarized data and Western blots of ERK1/2 phosphorylation (P-ERK1/2), total ERK1/2, and endothelial nitric oxide synthase (eNOS) from a typical experiment are shown in A. Results are mean±SE of 3 independent experiments. *P<0.05 vs loaded controls. B and C show the presence of ERK1/2 in caveolin (Cav-1)-containing fraction after sucrose density fractionation of control and cholesterol-depleted veins, respectively. Blots are representative of 3 independent experiments.

Effect of Cholesterol Extraction on Subcellular Distribution of ERK1/2

With the use of sucrose gradient fractionation, ERK1/2 was found to copurify with the caveolar marker protein caveolin-1 (Figure 6B). Cholesterol depletion did not appear to alter the distribution of either caveolin-1 or ERK1/2 (Figure 6C).

Discussion

The observation that stretch increases P-Tyr preferentially in membrane microdomains containing caveolin-1 prompted us to examine the growth response after manipulation of caveolae. The effects of mβcd are specific for cholesterol extraction, because cholesterol-saturated mβcd had no effect on the growth response to stretch. The partial recovery of growth after reloading with cholesterol after depletion is likely due to incomplete restoration of cholesterol contents, because delivery of cholesterol is several-fold less effective than depletion by cyclodextrins.29

Even though cholesterol depletion influences caveolar structure and much evidence suggests that this affects signaling mechanisms located in lipid rafts/caveolae, the possibility remains that its functional consequences are linked, at least partly, to altered membrane fluidity. Removal of cholesterol from the membrane will increase its stiffness and thus perhaps the degree of mechanical deformation in response to an applied load. It is notable that limited extraction (1 hour) of cholesterol caused only regional disruption of caveolae yet inhibited growth completely. This might indicate that the effects on growth do not involve the caveolar structure per se but rather the liquid-ordered state normally present in either caveolae or rafts,17 which might influence mechanical forces acting on resident proteins.

Strain on the extracellular matrix and membrane integrins, which are attached to the cytoskeleton, influences gene expression, which accordingly is affected by manipulation of either matrix/integrin interactions,6 formation and receptor binding of endogenous growth factors,12,14,16⇓⇓ or cytoskeletal integrity.7,16⇓ The present study implicates cholesterol-rich, membrane domains in the sequence. Mechanical stress is transmitted from contractile and cytoskeletal filaments to the plasma membrane, where adherens junctions constitute specific anchorage sites.30 Even though cholesterol depletion might influence signaling pathways involving the cytoskeleton, our results demonstrate that active force generated by a stimulus independent of caveolar signaling was unaffected by cholesterol depletion, indicating that both the myofilaments and the force transmission from them function normally.

ERK1/2 activation by stretch in the rat portal vein is partly inhibited by candesartan, a blocker of the type 1 angiotensin (AT1) receptors, and by captopril, an inhibitor of angiotensin-converting enzyme, showing that endogenous Ang II plays an important role in ERK1/2 activation.16 Selective MEK inhibition by PD 98059 reduces ERK phosphorylation by 70% and completely inhibits stretch-sensitive growth in the portal vein.10 Thus, the reduced ERK1/2 phosphorylation after cholesterol depletion is sufficient to inhibit the growth response. Because AT1 receptors translocate to caveolae on ligand binding,18 we speculated that ERK1/2 activation was inhibited at this level. However, exogenous Ang II still activated ERK1/2 in the portal vein after cholesterol depletion. In cultured vascular smooth muscle cells, transactivation of epidermal growth factor receptors by Ang II was inhibited by cholesterol depletion, whereas c-Src activation and intracellular Ca2+ response to Ang II were unaffected.31 These results suggest that pathways downstream of the AT1 receptor might have a different dependence on cholesterol and/or caveolin-1.

In the portal vein, ERK1/2 copurified with the caveolar marker protein caveolin-1. Cholesterol depletion did not, however, affect the position of either caveolin-1 or ERK1/2 in the sucrose gradient, suggesting that the inhibition of stretch-mediated ERK1/2 activation after cholesterol depletion was not due to disrupted membrane targeting of ERK1/2. The unimpaired ERK1/2 response to Ang II also suggests that the function of the kinase was unaffected by cholesterol depletion.

The role of ET-1 in vascular growth seems to be partially linked to that of Ang II, because Ang II infusion causes increased ET-1 expression, and the ensuing hypertension is corrected by an ETA antagonist.32 Endogenous ET-1 release might thus account for some of the vascular effects ascribed to Ang II. In our experiments, both an ETA receptor antagonist (RF139317) and an endothelin-converting enzyme inhibitor reduced ERK1/2 phosphorylation in stretched veins. A small effect of RF139317 in unloaded veins was also observed, suggesting that basal ERK1/2 phosphorylation is associated with constitutive ET-1 signaling. Stretch activated ERK1/2 when portal veins were bathed with a high ET-1 concentration, implying that whereas ET-1 is critical, it is not the only relevant factor for activation of ERK1/2 by stretch. Using a similar approach, we have shown that a saturating concentration of Ang II does not eliminate stretch-dependent growth in the portal vein.16 Whereas ERK1/2 activation by exogenous ET-1 was highly sensitive to cholesterol depletion, this was not the case for Ang II. It is therefore unlikely that ET-1 acts downstream of Ang II, but rather in parallel, while possibly being released via a common mechanism. The cholesterol sensitivity of ERK 1/2 activation by ET-1 is consistent with a similar sensitivity of contractile responses28 and with a reported localization of ETA receptors in caveolae.33

ERK1/2 activation by stretch was found to be insensitive to removal of the endothelium, and thus, the stretch-sensing mechanisms that affect gene expression in smooth muscle cells seem to primarily reside in these cells themselves. Substantial evidence indicates that endothelial cells are sensitive to shear stress in a manner dependent on intact caveolae.23–25⇓⇓ Thus, mechanical sensing in the vascular wall involves 2 separate modalities, wall tension and shear stress, which are transmitted through similar cholesterol-rich structures in entirely different cell types. This similarity argues that a role for caveolae in mechanotransduction might be a general phenomenon.

Acknowledgments

This study was supported by the Swedish Research Council (VR71X-28), the Heart-Lung Foundation, the Royal Physiographic Society, the Crafoord Foundation, and the Magnus Bergvall Foundation.

  • Received April 10, 2003.
  • Accepted July 4, 2003.

References

  1. ↵
    Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982; 62: 347–504.
    OpenUrlFREE Full Text
  2. ↵
    Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension. 2000; 36: 312–318.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Sarjeant JM, Rabinovitch M. Understanding and treating vein graft atherosclerosis. Cardiovasc Pathol. 2002; 11: 263–271.
    OpenUrlCrossRefPubMed
  4. ↵
    Owens GK. Molecular control of vascular smooth muscle differentiation. Acta Physiol Scand. 1998; 164: 623–635.
    OpenUrlPubMed
  5. ↵
    Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995; 75: 519–560.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Wilson E, Sudhir K, Ives HE. Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions. J Clin Invest. 1995; 96: 2364–2372.
  7. ↵
    Numaguchi K, Eguchi S, Yamakawa T, Motley ED, Inagami T. Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments. Circ Res. 1999; 85: 5–11.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Klinghoffer RA, Sachsenmaier C, Cooper JA, Soriano P. Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 1999; 18: 2459–2471.
    OpenUrlAbstract
  9. ↵
    Birukov KG, Lehoux S, Birukova AA, Merval R, Tkachuk VA, Tedgui A. Increased pressure induces sustained protein kinase C–independent herbimycin A–sensitive activation of extracellular signal–related kinase 1/2 in the rabbit aorta in organ culture. Circ Res. 1997; 81: 895–903.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Zeidan A, Nordström I, Dreja K, Malmqvist U, Hellstrand P. Stretch-dependent modulation of contractility and growth in smooth muscle of rat portal vein. Circ Res. 2000; 87: 228–234.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Levy BI, Michel JB, Salzmann JL, Azizi M, Poitevin P, Safar M, Camilleri JP. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res. 1988; 63: 227–239.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Bardy N, Merval R, Benessiano J, Samuel JL, Tedgui A. Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta; evidence for a pressure-induced tissue renin-angiotensin system. Circ Res. 1996; 79: 70–78.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens. 2001; 14: 83S–89S.
    OpenUrlCrossRefPubMed
  14. ↵
    Wilson E, Mai Q, Sudhir K, Weiss RH, Ives HE. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol. 1993; 123: 741–747.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Xu Q, Liu Y, Gorospe M, Udelsman R, Holbrook NJ. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest. 1996; 97: 508–514.
    OpenUrlCrossRefPubMed
  16. ↵
    Zeidan A, Nordström I, Albinsson S, Malmqvist U, Swärd K, Hellstrand P. Stretch-induced contractile differentiation of vascular smooth muscle: sensitivity to actin polymerization inhibitors. Am J Physiol Cell Physiol. 2003; 284: C1387–C1396.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Galbiati F, Razani B, Lisanti MP. Emerging themes in lipid rafts and caveolae. Cell. 2001; 106: 403–411.
    OpenUrlCrossRefPubMed
  18. ↵
    Ishizaka N, Griendling KK, Lassegue B, Alexander RW. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension. 1998; 32: 459–466.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000; 1: 31–39.
    OpenUrlCrossRefPubMed
  20. ↵
    Shaul PW, Anderson RG. Role of plasmalemmal caveolae in signal transduction. Am J Physiol. 1998; 275: L843–L851.
  21. ↵
    Lisanti MP, Tang ZL, Sargiacomo M. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae. J Cell Biol. 1993; 123: 595–604.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Rothberg KG, Ying YS, Kamen BA, Anderson GW. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J Cell Biol. 1990; 111: 2931–2938.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Park H, Go YM, St John PL, Maland MC, Lisanti MP, Abrahamson DR, Jo H. Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase. J Biol Chem. 1998; 273: 32304–32311.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Rizzo V, Sung A, Oh P, Schnitzer JE. Rapid mechanotransduction in situ at the luminal cell surface of vascular endothelium and its caveolae. J Biol Chem. 1998; 273: 26323–26329.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Park H, Go YM, Darji R, Choi JW, Lisanti MP, Maland MC, Jo H. Caveolin-1 regulates shear stress-dependent activation of extracellular signal-regulated kinase. Am J Physiol. 2000; 278: H1285–H1293.
    OpenUrl
  26. ↵
    Vinten J, Voldstedlund M, Clausen H, Christiansen K, Carlsen J, Tranum-Jensen J. A 60-kDa protein abundant in adipocyte caveolae. Cell Tissue Res. 2001; 305: 99–106.
    OpenUrlCrossRefPubMed
  27. ↵
    Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains: detergent-free purification of caveolae microdomains. J Biol Chem. 1996; 271: 9690–9697.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Dreja K, Voldstedlund M, Vinten J, Tranum-Jensen J, Hellstrand P, Sward K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler Thromb Vasc Biol. 2002; 22: 1267–1272.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Levitan I, Christian AE, Tulenko TN, Rothblat GH. Membrane cholesterol content modulates activation of volume-regulated anion current in bovine endothelial cells. J Gen Physiol. 2000; 115: 405–416.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Small JV, Gimona M. The cytoskeleton of the vertebrate smooth muscle cell. Acta Physiol Scand. 1998; 164: 341–348.
    OpenUrlCrossRefPubMed
  31. ↵
    Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK, Alexander RW. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem. 2001; 276: 48269–48275.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Rajagopalan S, Laursen JB, Borthayre A, Kurz S, Keiser J, Haleen S, Giaid A, Harrison DG. Role for endothelin-1 in angiotensin II–mediated hypertension. Hypertension. 1997; 30: 29–34.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Chun M, Liyanage UK, Lisanti MP, Lodish HF. Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc Natl Acad Sci U S A. 1994; 91: 11728–11732.
    OpenUrlAbstract/FREE Full Text
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Arteriosclerosis, Thrombosis, and Vascular Biology
September 2003, Volume 23, Issue 9
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Cholesterol Dependence of Vascular ERK1/2 Activation and Growth in Response to Stretch
    Asad Zeidan, Jonas Broman, Per Hellstrand and Karl Swärd
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1528-1534, originally published August 7, 2003
    https://doi.org/10.1161/01.ATV.0000090129.75275.C2

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Arteriosclerosis, Thrombosis, and Vascular Biology.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Cholesterol Dependence of Vascular ERK1/2 Activation and Growth in Response to Stretch
    (Your Name) has sent you a message from Arteriosclerosis, Thrombosis, and Vascular Biology
    (Your Name) thought you would like to see the Arteriosclerosis, Thrombosis, and Vascular Biology web site.
  • Share on Social Media
    Cholesterol Dependence of Vascular ERK1/2 Activation and Growth in Response to Stretch
    Asad Zeidan, Jonas Broman, Per Hellstrand and Karl Swärd
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1528-1534, originally published August 7, 2003
    https://doi.org/10.1161/01.ATV.0000090129.75275.C2
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Intervention, Surgery, Transplantation
    • Pharmacology
  • Vascular Disease
    • Restenosis
  • Heart Failure and Cardiac Disease
    • Remodeling
    • Hypertrophy
  • Basic, Translational, and Clinical Research
    • Cell Signaling/Signal Transduction

Arteriosclerosis, Thrombosis, and Vascular Biology

  • About ATVB
  • AHA CME
  • Meeting Abstracts
  • Permissions
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Contact the Editorial Office:
email: atvb@atvb.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured